BIT Capital’s Sana Biotechnology SANA Stock Holding History

BIT Capital’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-58,000	Closed	-$236K	–	118
2025 Q4	$236K	Buy	+58,000	New	+$260K	0.01%	95

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

BIT Capital's SANA Position: Q1 2026 in Review

BIT Capital sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 58,000 shares — an estimated $236K sold.

BIT Capital first reported a position in SANA in Q4 2025 and held it in 1 quarter. The position peaked at $236K in Q4 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

BIT Capital reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
BIT Capital sold 58,000 Sana Biotechnology shares in Q1 2026, an estimated $236K.
BIT Capital first reported a position in Sana Biotechnology in Q4 2025 and held it in 1 quarter.
BIT Capital's Sana Biotechnology position peaked at $236K in Q4 2025.
203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on BIT Capital's 13F filing for Q1 2026, filed 13 May 2026.